M Kraj

Instytut Hematologii i Transfuzjologi — Poland

Medicine · Health Sciences

9h-index311citations96works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(43), Chronic Lymphocytic Leukemia Research(16), Bone health and treatments(10), Monoclonal and Polyclonal Antibodies Research(9), Amyloidosis: Diagnosis, Treatment, Outcomes(9)

Publications96 total

Nietypowa lokalizacja złogów amyloidu w szpiczaku plazmocytowym
Hematologia·2016Open Access
High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma
Leukemia & lymphoma/Leukemia and lymphoma·2015· 7 cited
Light Chain Escape in 3 Cases: Evidence of Intraclonal Heterogeneity in Multiple Myeloma from a Single Institution in Poland
Case Reports in Hematology·2015· 5 citedOpen Access
Immunoglobulin Heavy Chain/Light Chain Pairs(Hlc, Hevylitetm) Assays for Diagnosingand Monitoring Monoclonal Gammopathies
Advances in Clinical and Experimental Medicine·2014· 18 citedOpen Access
Clonal Evolution In Two Multiple Myeloma Patients and a Biclonal MGUS Patient
Blood·2013
An Intact Immunoglobulin IgAλ Multiple Myeloma Patient Exhibiting Light Chain Escape
Blood·2012
Serum immunoglobulin heavy/light chain (HLC) and free light chain (FLC) concentrations at diagnosis in multiple myeloma and IgM malignant lymphoma patients with survival exceeding 10 years
Acta Haematologica Polonica·2012· 2 cited
Comparison of immunoglobulin free light chain (FLC), heavy chain/light chain (HLC) assays and immunofixation (IFE) in assessment of remission in multiple myeloma
Acta Haematologica Polonica·2012· 6 cited
Flow cytometric immunophenotypic characteristics of plasma cell leukemia
Folia Histochemica et Cytobiologica·2011· 12 citedOpen Access
Flow cytometric immunophenotypic characteristics of plasma cell leukemia
SHILAP Revista de lepidopterología·2011· 1 citedOpen Access
Skuteczne leczenie chorego na szpiczaka plazmocytowego IgE przy użyciu programu PAD (bortezomib, doksorubicyna, deksametazon) i autologicznego przeszczepienia krwiotwórczych komórek macierzystych – pierwszy przypadek szpiczaka IgE w Polsce
Nowotwory Journal of Oncology·2011
Complete remission following treatment with bortezomib, doxorubicin, dexamethasone and autologous stem cell transplant in patient with immunoglobulin E multiple myeloma
Leukemia & lymphoma/Leukemia and lymphoma·2010· 1 cited
Flow cytometric immunophenotypic characteristics of 36 cases of plasma cell leukemia
Leukemia Research·2010· 46 cited
Bortezomib in multiple myeloma: treatment and retreatment. A single center experience.
PubMed·2009· 6 cited
Efficacy and safety of thalidomide in the treatment of multiple myeloma.
PubMed·2009· 2 cited
Skuteczność i bezpieczeństwo leczenia białaczki plazmocytowej według programu PAD (bortezomib + doksorubicyna + deksametazon)
Nowotwory Journal of Oncology·2009
Synchroniczne zachorowanie na nowotwór podścieliska przewodu pokarmowego i szpiczaka
2009
Synchronous appearance of gastrointenstinal stromal tumor and myeloma plasmocyticum with c-kit expression - a case report
Oncology in Clinical Practice·2009
Clinicopathological correlates of plasma cell CD56 (NCAM) expression in multiple myeloma
Leukemia & lymphoma/Leukemia and lymphoma·2008· 37 cited
The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
PubMed·2007· 8 cited
page 1 of 5Next →

Frequent Co-authors

Ryszard Pogłód(18), Barbara Kruk(13), J Rostkowska(11), J Snigurowicz(10), Krzysztof Warzocha(7), S Cieśluk(7), Joanna Kopeć‐Szlęzak(6), Urszula Sokołowska(6), S Maj(5), Jolanta Woźniak(3), J Pawlikowski(3), W Ławkowicz(3), I Krzemińska-Lawkowiczowa(3), M Słomkowski(3), Tomasz Szpila(2), Z Zawadzki(2), Katarzyna Owczarska(2), Piotr Centkowski(2), S Maj(2), Maj S(2)